As many as 12 million individuals in the United States are infected with sexually transmitted diseases (STDs) each year, and many of these infections result in serious reproductive sequelae (3). Since current prevention strategies have been only partially successful, the use of topical microbicides offers a new approach to the prevention of STDs that is particularly attractive in that they are broad spectrum in their activity and can be self administered by women before sexual contact. An ideal microbicide would prevent STDs caused by bacterial pathogens such as Chlamydia trachomatis and Neisseria gonorrhoeae, as well as those caused by human immunodeficiency virus, human papillomavirus, herpes simplex viruses, and the parasite Trichomonas vaginalis. In addition, such preparations should be spermicidal but should not disrupt the normal flora or be toxic to the vaginal epithelium. Since C. trachomatis is the most common bacterial cause of STDs in the United States (1), accounting for at least one-third of all these infections, we have focused our efforts on this pathogen.
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Human breast milk contains numerous antimicrobial compounds (5), some of which are lipid based. We have modified some of these antimicrobial lipids to increase their stability and aqueous solubility while maintaining their antimicrobial activity and then synthesized these compounds for use in antimicrobial assays. These novel lipids have been shown to have inhibitory activity against Escherichia coli, Salmonella enteritidis, and Staphylococcus epidermidis (4) , but their activity against Chlamydia is unknown. C. trachomatis is transmitted from an infected to an uninfected individual in genital secretions via sexual contact. Even though C. trachomatis is an obligate intracellular bacterium, the elementary body (EB) or infectious form of the organism is found extracellularly in secretions. EBs are adapted for survival in cell-free conditions but are susceptible in vitro to various antimicrobials such as detergents (7), peptides (11), whole human milk, and fractions of it (2) . We undertook these studies to examine whether genital strains of C. trachomatis were killed by these novel antimicrobial lipids adapted from human breast milk. Five lipids, including 1-and 2-O-hexyl-sn-glycerol, 1-O-heptyl-snglycerol, and 1-and 2-O-octyl-sn-glycerol, were examined in an in vitro C. trachomatis viability assay and assessed for their morphologic effects upon C. trachomatis EBs by electron microscopy.
MATERIALS AND METHODS
Cell culture. Low-passage (Ͻ15 passages) McCoy mouse fibroblast cells (ATCC CRL 1696) were maintained in antibiotic-free Eagle's minimal essential medium with 10% fetal calf serum (EMEM). The McCoy cells were checked routinely once per month for mycoplasma contamination.
Inoculum. C. trachomatis serovars D (UW-3/Cx) and F (UW-6/Cx) were grown in McCoy cells in antibiotic-free EMEM, purified on Renografin gradients, and stored at Ϫ70°C in SPG (219 mM sucrose, 3.8 mM KH 2 PO 4 , 8.6 mM Na 2 HPO 4 , 4.9 mM glutamic acid [pH 7.0]). Immediately prior to use, the purified organisms were thawed and diluted in SPG.
Novel lipids. Five lipids, including 1-and 2-O-hexyl-sn-glycerol, 1-O-heptylsn-glycerol, and 1-and 2-O-octyl-sn-glycerol, were tested. The structures of these lipids are shown in Fig. 1 . The lipids were designed by C. E. Isaacs and synthesized by Deva Biotech (Hatboro, Pa.). Each lipid was received as a 100ϫ solution in 100% ethyl alcohol (EtOH). The 1-and 2-O-hexyl-sn-glycerol ethers were diluted to an initial concentration of 15 mM (2.64 mg/ml), and the 1-O-heptylsn-glycerol ether and 1-and 2-O-octyl-sn-glycerol ethers were diluted to 50 mM (10.2 mg/ml) in SPG or EMEM. After each dilution, the lipids were vortexed for 15 to 30 s to ensure their even distribution.
Controls. Polymyxin B and penicillin G were used as positive and negative controls, respectively, at an initial concentration of 2 mg/ml in the preinoculation assays. EMEM and EtOH were used as controls in the alamarBlue cell toxicity assay. All controls were prepared fresh on the day of the assay.
Preinoculation assay. C. trachomatis serovar D or F (10 6 inclusion-forming units [IFU] ) in SPG was added to dilutions of each lipid or positive or negative control antibiotics (polymyxin B and penicillin G) and incubated for 0, 30, 60, 90, or 120 min. After each time period, a 5-l aliquot of the organism-drug mixture was diluted 1:40 in 195 l of SPG. One hundred microliters of this dilution was then added to a McCoy cell monolayer in a 96-well microtiter plate and centrifuged for 1 h to inoculate the tissue culture cells. The organism-drug mixture was then removed and replaced with EMEM containing 1 g of cycloheximide per ml. The cultures were incubated for 48 h and stained with the Chlamydia genusspecific fluorescein isothiocyanate-labeled monoclonal antibody CF2, and the chlamydial inclusions in three fields were counted. All assays were performed in triplicate, the inclusion counts were averaged, and the polymyxin B positive control and the penicillin G negative control were run in parallel. Additional wells were inoculated either with the C. trachomatis organisms only, which served as an organism control, or with SPG only, to monitor McCoy cell morphology. Percent killing in tests with lipid, the polymyxin B positive control, and the penicillin G negative control were calculated by the following formula: [(mean IFU of organism control Ϫ mean IFU of test)/(mean IFU of organism control)] ϫ 100. The lowest concentration of lipid which showed 100% killing was defined as the minimal cidal concentration (MCC). One hundred percent killing represents a decrease of at least 10 4 organisms, from the original 10 6 IFU in the inoculum to 160 IFU, the minimum number of IFU which can be counted in our assay.
alamarBlue cytotoxicity assay. The preinoculation assay was duplicated except that no Chlamydia organisms were added. Lipid dilutions were further diluted 1:40 in EMEM as in the preinoculation assay and then added to 24-h monolayers of McCoy cells in 96-well microtiter plates and incubated for 1 h. Lipid dilutions were aspirated from the wells and replaced with EMEM containing 1 g of cycloheximide per ml, and cultures were incubated for 48 h. alamarBlue (Alamar Biosciences, Inc., Sacramento, Calif.) was then added to each well, and the cells were incubated for 4 h. alamarBlue is chemically reduced by the metabolic activity of growing cells, which causes the fluorometric-colorimetric REDOX indicator to change from an oxidized, nonfluorescent blue form to a reduced, fluorescent red form. The optical densities of the wells (OD 570 and OD 600 ) were read, and percent inhibition of McCoy cells was calculated in comparison to that of EMEM negative controls by the following formula: percent inhibition ϭ [(mean OD 570 Ϫ mean OD 600 of negative cell control) Ϫ (mean OD 570 Ϫ mean OD 600 of test)]/[mean OD 570 Ϫ mean OD 600 of negative cell control] ϫ 100 (9) .
Preinoculation assay in the presence of 10% human blood. The preinoculation assay described above was used with the addition of 10% whole human blood. Blood was collected from one of the authors who was not receiving antibiotics and who has no antichlamydial antibodies, as measured by microimmunofluorescence (10) . The pH of the lipid dilutions was adjusted to pH 7.0. Assays were performed only at 0-and 120-min time points. Ten percent human blood was also added to the organism controls.
Preinoculation assay with pH alterations. The preinoculation assay described above was followed except that lipid dilutions were adjusted to pH 4, 5, 6, 7, or 8 with 1 M Na 2 HPO 4 or 1 M KH 2 PO 4 before C. trachomatis IFU were added. Again, assays were performed only at 0-and 120-min time points and all controls were tested at each different pH value.
FIG. 2.
Comparison of the antichlamydial activities of the five novel lipids examined in these studies. The preinoculation assay was used, and the percent killing of C. trachomatis serovar D after 120 min of exposure to each lipid or the controls was plotted. The initial concentrations of polymyxin B and penicillin G were 2,000 g/ml.
Electron microscopic examination of C. trachomatis exposed to lipids. The lowest concentration of each of the lipids showing 100% killing in the preinoculation assay was incubated with C. trachomatis EBs for 90 min. The treated organisms were pelleted, fixed with 2% glutaraldehyde, postfixed in 1% osmium tetroxide in deionized water, dehydrated in a series of alcohols, embedded in EMbed 812 (Electron Microscope Supplies, Chestnut Hill, Mass.), thin sectioned, stained with uranyl acetate and lead citrate, and examined in a Philips (Eindhoven, The Netherlands) model CM-10 transmission electron microscope. Organisms exposed to SPG were treated as described above and examined for typical morphology.
RESULTS

Comparison of the antichlamydial activities of the five lipids.
The antichlamydial activities of all five lipids against C. trachomatis serovar D at 120 min are shown in Fig. 2 . It is important to note that the 2-and 1-O-octyl-sn-glycerol derivatives showed 100% killing at lower concentrations (7.5 and 15 mM respectively) whereas the 1-O-heptyl-sn-glycerol and 1-and 2-O-hexyl-sn-glycerol derivatives showed 100% killing only at higher concentrations (25 to 50 mM). Table 1 icity assay. This assay detects low levels of toxicity resulting in cell changes that are not microscopically visible. However, none of the dilutions of the lipids used in the preinoculation assay showed significant cytotoxicity. Results with 2-O-octylsn-glycerol are shown in Table 2 . The other lipids showed similar negative results.
Comparison of lipid activities against C. trachomatis serovars D and F. To determine whether these antimicrobial lipids were active against different serovars of C. trachomatis, dilutions of all the lipids were tested against both serovars D and F for various periods of time. Results with 2-O-octyl-sn-glycerol at 0 and 120 min are shown in Fig. 3 and indicate that it was equally active against both serovars, with an MCC of 7.5 mM at 120 min for both organisms. In general, the other lipids showed more killing of serovar F than of serovar D, but both serovars were killed after 120 min. 1-O-Hexyl-sn-glycerol was the exception because it never completely killed serovar D even after 120 min.
Lipid activity in the presence of 10% human blood. To directly test whether the activity of these lipids would be reduced in the presence of human blood found in the vagina during the menstrual cycle, the preinoculation assay was performed in parallel in the presence and absence of 10% whole human blood. Figure 4 shows the results comparing 2-O-octylsn-glycerol activities against C. trachomatis serovar D with and without 10% human blood after 0 and 120 min of exposure. The MCC with blood (15 mM) was one dilution higher than that without blood (7.5 mM) after 120 min. Blood, therefore, has a small but most likely insignificant effect on lipid antichlamydial activity.
Lipid activity at pH 4, 5, 6, 7, and 8. Because the pH can vary widely in the human vagina, we tested the activity of the lipids at pH 4, 5, 6, 7, and 8 against C. trachomatis serovar D for 0 and 120 min. As shown in Fig. 5, 2 -O-octyl-sn-glycerol at a few pH-concentration combinations showed increased (pH 8, 3.75 mM) or decreased (pH 6, 7.5 mM) killing of C. trachomatis serovar D when the organism was exposed to the lipid for 120 min. In general, however, differences in pH did not have a major impact on 2-O-octyl-sn-glycerol activity (Table 3) .
Examination by electron microscopy of C. trachomatis exposed to lipids. Chlamydia organisms exposed to the lowest concentration of each of the lipids that resulted in 100% killing in the preinoculation assay were examined by transmission electron microscopy. After incubation with the most active 2-and 1-O-octyl-sn-glycerol derivatives, only C. trachomatis ghosts containing outer membrane shells and no cytoplasmic contents remained (similar to the organism visible on the left in Fig. 6B ). After incubation with the less active lipids, 2-and 1-O-hexyl-sn-glycerol derivatives, not only hollow ghosts but also organisms in the process of leaking their cytoplasmic contents could be seen (organism visible on the right in Fig. 6B) . In both cases, it appeared that the inner membrane of Chlamydia was disrupted while most of the outer membrane remained intact. We did not examine the 1-O-heptyl-sn-glycerol activity by electron microscopy.
DISCUSSION
The development of a topical microbicide that is safe, inexpensive, easy to use, and effective against the most common STD pathogens could be of great importance in reducing the transmission of STDs. The lipids we have examined in these studies may contribute toward achieving this goal. The 2-Ooctyl-sn-glycerol lipid was the most active of the five closely Lipids, which disrupt the lipid bilayers of pathogens, might also disrupt cell membranes they come into contact with, including the epithelial cells lining the human vagina. Toxicity of this type caused by lipids applied to mucosal surfaces would likely be at least partly prevented by the mucous layer. Under the conditions of our assay utilizing 1 h of contact of a 1:40 dilution of the lipid concentrations tested, we found that the lipids were not toxic to McCoy cells as determined by the alamarBlue test. However, toxicity of these lipids is an important issue which needs to be examined in future studies of humans and in animal models.
Since there are numerous different C. trachomatis serovars which can cause urogenital disease, we wanted to determine whether these antimicrobial lipids were active against different serovars. Of the lipids tested, none showed significant variability in activity when two different serovars, D and F, were tested. For example, the same concentration of 2-O-octyl-sn-glycerol necessary to kill serovar D (7.5 mM) was also completely active against serovar F. While additional strains and serovars need to be tested, these results suggest that a topical 2-O-octyl-snglycerol preparation would likely be broadly active against many or most of the C. trachomatis serovars associated with STDs.
In addition to lipids, there are other classes of antimicrobials such as naturally occurring antimicrobial peptides that could be used as topical microbicides. One potential problem with defensins and other antimicrobial peptides is their reduced activity in the presence of serum (8) . During the menstrual period, topically applied defensins would come in contact with serum proteins contained in menstrual blood, thus diminishing their activity. The short-chain monoglycerides examined in these studies could bind to proteins such as albumin or to other proteins with fatty acid binding sites that are found in blood (4) . However, the activity of the lipids examined in these studies was not decreased by the presence of 10% whole human blood. These results indicate that a topical lipid preparation would likely remain active even during the menstrual period, when other antimicrobial compounds such as defensins might have reduced activity.
The pH of the human vagina varies greatly, from pH 4 in healthy women to pH 5 to 6 in women with bacterial vaginosis, pH 7 in women who are postmenopausal, and pH 8 after semen is deposited. Since the ideal topical antimicrobial should be effective at all of these different pH values, we examined the activity of the lipids at pH 4, 5, 6, 7, and 8. There are some changes in the activity of 2-O-octyl-sn-glycerol at pH values other than 7, but these changes are likely not biologically significant. Our results indicate that a topical lipid preparation would be active under a wide variety of pH conditions in the female genital tract. Antimicrobial lipids are thought to be active because they disrupt lipid bilayers. The electron micrographic examination of Chlamydia treated with these lipids confirms the results in the preinoculation MCC assays. The lipids were observed to disrupt the chlamydial inner membrane, allowing the cytoplasmic contents to leak out of the cell and confirming that the lipids are directly active against the organism. The absence of cellular toxicity observed in the alamarBlue test is also consistent with the conclusion that the antichlamydial activity of these lipids results directly from disruption of the chlamydial membrane and not from toxicity to the McCoy cells.
In conclusion, these lipids, which are related to the antimicrobial monoglyceride esters found in human breast milk (6) , are able to kill C. trachomatis directly; 2-O-octyl-sn-glycerol is the most active of those tested. Further tests to determine whether they are active against other chlamydial strains and other STD pathogens are under way. Given further testing of toxicity and efficacy in humans, it is possible that these lipids would make an effective topical microbicide to kill sexually transmitted Chlamydia on contact at the time of sexual transmission, before infection occurs. These naturally occurring compounds, found in humans at mucosal membranes, are likely to be relatively nontoxic and may be well suited for this proposed use.
